Banque Cantonale Vaudoise Acquires 9,733 Shares of The Clorox Company $CLX

Banque Cantonale Vaudoise raised its holdings in The Clorox Company (NYSE:CLX) by 78.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 22,072 shares of the company’s stock after buying an additional 9,733 shares during the period. Banque Cantonale Vaudoise’s holdings in Clorox were worth $2,225,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Center for Financial Planning Inc. bought a new stake in Clorox in the third quarter valued at approximately $25,000. Vermillion & White Wealth Management Group LLC bought a new position in shares of Clorox during the third quarter worth approximately $25,000. Darwin Wealth Management LLC bought a new position in shares of Clorox during the second quarter worth approximately $29,000. Root Financial Partners LLC bought a new position in shares of Clorox during the third quarter worth approximately $29,000. Finally, Vision Financial Markets LLC increased its stake in shares of Clorox by 166.7% during the fourth quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after purchasing an additional 200 shares during the period. Institutional investors own 78.53% of the company’s stock.

Clorox Trading Up 1.0%

Shares of CLX stock opened at $95.18 on Friday. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The Clorox Company has a fifty-two week low of $84.70 and a fifty-two week high of $132.03. The company has a market cap of $11.51 billion, a PE ratio of 15.45, a P/E/G ratio of 0.49 and a beta of 0.59. The stock’s fifty day moving average price is $100.33 and its two-hundred day moving average price is $106.37.

Clorox (NYSE:CLX) last released its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The company had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. During the same quarter last year, the business posted $1.45 EPS. Clorox’s revenue for the quarter was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities analysts predict that The Clorox Company will post 5.61 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 8th. Investors of record on Wednesday, April 22nd were issued a dividend of $1.24 per share. The ex-dividend date of this dividend was Wednesday, April 22nd. This represents a $4.96 annualized dividend and a dividend yield of 5.2%. Clorox’s dividend payout ratio (DPR) is 80.52%.

Insider Buying and Selling at Clorox

In other news, Director Pierre R. Breber acquired 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 5th. The shares were bought at an average price of $85.82 per share, with a total value of $429,100.00. Following the acquisition, the director directly owned 18,000 shares in the company, valued at $1,544,760. The trade was a 38.46% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. 0.63% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on CLX. UBS Group lowered their target price on Clorox from $110.00 to $96.00 and set a “neutral” rating on the stock in a research note on Friday, May 1st. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $91.00 price objective on shares of Clorox in a research note on Friday, May 1st. Royal Bank Of Canada lowered their price objective on Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research note on Thursday, April 9th. Evercore restated an “underperform” rating and set a $110.00 price objective on shares of Clorox in a research note on Friday, May 1st. Finally, Wells Fargo & Company lowered their price objective on Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a research note on Monday. One equities research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Reduce” and an average price target of $103.40.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.